APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $182,516 | +58.9% | 4,798 | +280.5% | 0.01% | +50.0% |
Q2 2023 | $114,877 | +66.5% | 1,261 | -40.0% | 0.01% | +60.0% |
Q3 2021 | $69,000 | -82.6% | 2,100 | -66.6% | 0.01% | -83.9% |
Q2 2021 | $397,000 | +2546.7% | 6,295 | +1159.0% | 0.03% | +1450.0% |
Q3 2020 | $15,000 | -62.5% | 500 | -70.6% | 0.00% | -50.0% |
Q3 2019 | $40,000 | -64.0% | 1,700 | -72.9% | 0.00% | -50.0% |
Q3 2018 | $111,000 | -9.8% | 6,269 | +11.3% | 0.01% | 0.0% |
Q2 2018 | $123,000 | – | 5,631 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |